Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.
Yu SunakawaYasutoshi KubokiJun WatanabeTetsuji TerazawaHiasto KawakamiMitsuru YokotaMasato NakamuraMasahito KotakaNaotoshi SugimotoHitoshi OjimaEiji OkiTakeshi KajiwaraYoshiyuki YamamotoYasushi TsujiTadamichi DendaTakao TamuraSoichiro IshiharaHiroya TaniguchiTakako Eguchi NakajimaSatoshi MoritaKuniaki ShiraoNaruhito TakenakaDaisuke OzawaTakayuki YoshinoPublished in: Targeted oncology (2024)
jRCTs031180122.